Beltrami G, Rüdiger H A, Mela M M, Scoccianti G, Livi L, Franchi A, Campanacci D A, Capanna R
Department of Orthopaedic Oncology, University of Florence, Careggi, Florence, Italy.
Eur J Surg Oncol. 2008 Jul;34(7):811-6. doi: 10.1016/j.ejso.2007.08.011. Epub 2007 Nov 5.
While combined treatment of high-grade soft tissue sarcoma with resection and radiotherapy has become an accepted standard, outlines of treatment algorithms remain a matter of debate. Our institutional practice foresees wide surgical resection with adjuvant brachytherapy and external beam radiation. It was the purpose of this study to determine long-term outcome, prognostic factors for local and systemic recurrence and morbidity in patients with high-grade soft tissue sarcomas of the extremities, who were subjected to this regimen. One hundred and twelve patients met the inclusion criteria (56 male, 56 female; median age, 50 years). Median follow-up was 75 months (min. 11 months). Overall survival rate was 77.5% and 71.1% at 5 and 7 years, respectively. Disease-free survival rate was 63.3% and 58.4% at 5 and 10 years, respectively. Local control was achieved in 91.5% and 87.0% at 5 and 10 years, respectively. Wide surgical margins were associated with a significantly better local control rate compared to marginal or intralesional margins. Tumor size did correlate with systemic but not local recurrence. Tumor site and histotype did not appear to have an impact on outcome. Chemotherapy did not show to have an impact on local or systemic control. Fourteen patients (12.5%) had local complications attributed to radiotherapy. Eleven patients developed wound-healing problems, which needed further surgery. Using our treatment algorithm for high-grade soft tissue sarcoma of the extremities, good local and systemic control can be achieved with a low complication rate.
虽然采用手术切除和放疗联合治疗高级别软组织肉瘤已成为公认的标准,但治疗方案的具体细节仍存在争议。我们机构的做法是进行广泛的手术切除,并辅以近距离放疗和外照射。本研究的目的是确定接受该治疗方案的四肢高级别软组织肉瘤患者的长期预后、局部和全身复发的预后因素以及发病率。112例患者符合纳入标准(男性56例,女性56例;中位年龄50岁)。中位随访时间为75个月(最短11个月)。5年和7年的总生存率分别为77.5%和71.1%。5年和10年的无病生存率分别为63.3%和58.4%。5年和10年的局部控制率分别为91.5%和87.0%。与边缘或瘤内切缘相比,广泛的手术切缘与显著更好的局部控制率相关。肿瘤大小与全身复发相关,但与局部复发无关。肿瘤部位和组织学类型似乎对预后没有影响。化疗对局部或全身控制没有影响。14例患者(12.5%)出现了归因于放疗的局部并发症。11例患者出现伤口愈合问题,需要进一步手术。采用我们针对四肢高级别软组织肉瘤的治疗方案,可以实现良好的局部和全身控制,且并发症发生率较低。